Risk of Melanoma Among Parkinson’s Disease Patients (TV1030-CNS-50024)

First published 23/07/2017

Last updated 02/07/2024

EU PAS number:

EUPAS19909

Study

Finalised

Documents

Study protocol

Study results

Study report

0303432_ICPE_Abstract_Main results_09Feb2021_final for submission

English (81.46 KB - PDF)View document

Other information

Study, other information

0303432_ICPE2021_Rasagiline and Melanoma_Final_11Aug2021

English (164.75 KB - PDF)View document

0303432_ICPE2021_Validation_Saltus_Final_11Aug2021

English (158.93 KB - PDF)View document

0303432_ICPE_Abstract_Validation_Rev Dec 2020_clean

English (127.58 KB - PDF)View document

Publications

Study publications

Secondary tabs